Platelet Function Completed Phase 4 Trials for Prasugrel (DB06209)

Back to Platelet Function
IndicationStatusPhase
DBCOND0041432 (Platelet Function)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02215993Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to ThrombolysisSupportive Care